SCHEMBL1444136

SCHEMBL1444136

O=C1Nc2ccccc2/C1=C\Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
ALDH1A1 P00352 3/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
KDM4E B2RXH2 1/20 0.54
PKM P14618 1/20 0.54
MAPK1 P28482 1/20 0.54
APP P05067 1/20 0.53
SNCA P37840 1/20 0.53
LMNA P02545 1/20 0.51
TGM2 P21980 1/20 0.51
HTT P42858 1/20 0.51
IDO1 P14902 1/20 0.51
FLT3 P36888 3/20 0.51
EPHX2 P34913 1/20 0.50
RPS6KA3 P51812 1/20 0.49
ALK Q9UM73 1/20 0.49
PIM1 P11309 1/20 0.49
KDR P35968 1/20 0.49
SYK P43405 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444503 1.00 MAPT (0.54) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL28213543 0.88 CCNB2 (0.57) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL6759292 0.82 CES1 (0.50) TGM2IDO1PDGFRB
SCHEMBL10189254 0.82 CES1 (0.50) TGM2IDO1PDGFRB
SCHEMBL7418882 0.81 PDGFRB (0.58) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL7421021 0.80 GSK3B (0.46) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL28394798 0.80 MAPT (0.50) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL1520390 0.79 PPARG (0.49) MAPTALDH1A1KDM4EPKMMAPK1
SCHEMBL28386248 0.76 MAPT (0.52) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E
SCHEMBL11887918 0.76 ALDH1A1 (0.51) MAPTALDH1A1SMN1; SMN2NPSR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2480530-A1 ALKENE OXINDOLE DERIVATIVES AND THEIR USES TO TREAT OBESITY, DIABETES AND HYPERLIPIDEMIA F. Hoffmann-La Roche AG (CH) 2012-08-01 EP disclosed
WO-2011033099-A1 ALKENE OXINDOLE DERIVATIVES AND THEIR USES TO TREAT OBESITY, DIABETES AND HYPERLIPIDEMIA F. HOFFMANN-LA ROCHE AG (CH) 2011-03-24 WO disclosed
WO-2011032320-A1 NOVEL ALKENE OXINDOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-03-24 WO disclosed